Hiroshi Okamoto, Akiko Kobayashi. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Antirheumatic Agents/adverse effectsAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyHumansIntracellular Signaling Peptides and Proteins/antagonists & inhibitorsLymphocyte Specific Protein Tyrosine Kinase p56(lck)/antagonists & inhibitorsNeutropenia/chemically inducedOxazines/adverse effectsOxazines/therapeutic useProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyridines/adverse effectsPyridines/therapeutic useSyk Kinasesrc-Family Kinases/antagonists & inhibitors
Substances： See more » Antirheumatic AgentsIntracellular Signaling Peptides and ProteinsOxazinesProtein Kinase InhibitorsPyridinesProtein-Tyrosine KinasesLymphocyte Specific Protein Tyrosine Kinase p56(lck)SYK protein, humanSyk Kinaselyn protein-tyrosine kinasesrc-Family Kinasesfostamatinib
Year: 2011 PMID： 21208113 DOI： 10.1056/NEJMc1012187
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245